NYSE · GMED
Globus Medical, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for GMED: Nov 05, 2026
Globus Medical, Inc. Class A Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $1.2. The reported EPS for the same quarter last year was $1.18.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $1.20 | $1.21 | $1.19 | 4 |
| Dec 2026 | $1.33 | $1.33 | $1.32 | 3 |
| Mar 2027 | $1.23 | $1.32 | $1.14 | 3 |
| Jun 2027 | $1.40 | $1.48 | $1.34 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks- Zacks · Oct 30, 1:56 PM EDTSYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutStryker shares plunge 11.8% after Q3 earnings and sales miss estimates, prompting a 2026 outlook cut amid weak joint procedures and execution challenges.
- Zacks · Oct 30, 10:00 AM EDTDexCom Stock Up on Q3 Earnings & Revenue Beat, Margins RiseDXCM shares rise as Q3 earnings and revenues beat estimates, margins expand and 2026 guidance improves, driven by strong U.S. demand and G7 15 Day adoption.
- Zacks · Oct 30, 9:57 AM EDTDaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YDVA's Q3 earnings surge 52.2% as revenues rise 4.6%, fueled by strong kidney care and international growth despite rising costs and margin pressure.
- Zacks · Oct 29, 12:24 PM EDTReasons to Hold Hinge Health Stock in Your Portfolio for NowHNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.
- Zacks · Oct 29, 11:06 AM EDTALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock FallsAlign Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.
- Zacks · Oct 29, 11:04 AM EDTWest Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook RaisedWST reports strong Q3 earnings and revenue growth, fueled by high-value products and margin expansion, and raises its 2026 sales and earnings outlook.
- Zacks · Oct 29, 10:48 AM EDTBaxter Q3 Earnings Beat on Broad-Based Growth, '26 Outlook RaisedBAX beats Q3 earnings and revenue estimates, driven by broad-based segment growth, and raises its 2026 outlook despite continued margin pressure.
- Zacks · Oct 29, 7:43 AM EDT2 Healthcare Technology Stocks for a Digital Health BoomGMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
- Zacks · Oct 28, 2:45 PM EDTUHS Misses Q3 Earnings Estimates Despite Higher Patient VolumesUniversal Health Services' Q3 earnings fall 8.3% despite revenue growth, as rising costs and Acute Care pricing pressure offset higher patient volumes.
- Zacks · Oct 28, 11:16 AM EDTSYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.
- Zacks · Oct 28, 11:16 AM EDTProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.
- Zacks · Oct 28, 10:05 AM EDTGEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View RaisedGE HealthCare's Q3 earnings and revenues beat estimates on strong segment growth and higher margins, driving raised 2026 guidance as shares gain 8.3%.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Globus Medical, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.